| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $50.5M | +85.9% |
| Cost of Revenue | $12.5M | +75.2% |
| Gross Profit | $38.0M | +89.7% |
| R&D Expense | $17.0M | +19.0% |
| SG&A Expense | $16.6M | +97.4% |
| Operating Income | -$30.6M | -26.7% |
| Interest Expense | $1.4M | +8.3% |
| Income Tax | $0 | — |
| Net Income | -$29.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $85.8M | +113.8% |
| Short-term Investments | $24.0M | — |
| Accounts Receivable | $11.4M | +67.9% |
| Inventory | $1.8M | +85.4% |
| Current Assets | $126.7M | +156.7% |
| Total Assets | $130.1M | +151.1% |
| Current Liabilities | $14.3M | +61.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.0M | -13.8% |
| Capital Expenditures | $642K | +256.7% |
| Investing Cash Flow | -$25.5M | — |
| Financing Cash Flow | $100.1M | +71.2% |
| Free Cash Flow | -$29.6M | -15.5% |
| -22.2% |
| EPS (Basic) | -$2.12 | +65.3% |
| EPS (Diluted) | -$2.12 | +65.3% |
| Long-term Debt |
| $15.3M |
| -0.4% |
| Total Liabilities | $31.3M | +19.2% |
| Stockholders' Equity | $98.9M | +240.0% |